Picture of Palatin Technologies logo

PTN — Palatin Technologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Palatin Technologies Q2 Loss Per Share $0.02

Palatin Technologies Inc  PTN.A :
    * PALATIN TECHNOLOGIES, INC. REPORTS SECOND QUARTER FISCAL
YEAR
2020 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
    * Q2 LOSS PER SHARE $0.02
    * DRY EYE DISEASE PHASE 2 STUDY TO COMMENCE Q1 2020
    * PALATIN TECHNOLOGIES- AMAG'S PLANNED DIVESTITURE OF
VYLEESI IS
BASED ON CHANGE IN STRATEGY, "AND IS NOT A RESULT OF VYLEESI
LAUNCH PERFORMANCE TO DATE"
    * PALATIN TECHNOLOGIES - DATA FROM DRY EYE DISEASE PHASE 2
STUDY
EXPECTED IN Q4 2020 & ULCERATIVE COLITIS TRIAL DATA EXPECTED IN
MID-CALENDAR YEAR 2021
    * QTRLY LICENSE AND CONTRACT REVENUE $20,610

Source text for Eikon:  ID:nPn3ZyRJLa 
Further company coverage:  PTN.A

Recent news on Palatin Technologies

See all news